RxDoctor Payments Data

James Morgan

Podiatrist · Mobile, ALNPI 1124019401

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Trice Medical, Inc. accounts for 74.1% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2023 at $12,940 and has fallen 93.5% since, to $836 in 2025. Among podiatrist clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$21,031in general payments, 2019–2025

Across 153 payments — averaging $137.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Trice Medical, Inc.$16K
  • Stryker$2K
  • Treace Medical Concepts, Inc.$1K
  • Amgen$318
  • Smith+Nephew$295
  • Musculoskeletal Transplant Foundation Inc.$266
  • plus $1K from 20 others

What the payments were for

  • Consulting fees$9,30044%
  • Travel & lodging$7,38935%
  • Food & beverage$4,31821%
  • Education$240%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,031 in reported general payments places this provider in the 95th percentile of 59 podiatrist providers in Alabama.

See all podiatrist providers in Alabama

Medicare billing

Part B allowed, 2024
$1,198,406
Medicare patients
534
Services billed
3,179

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole120$3,953
Linezolid15$1,116
Gabapentin83$485
CiclopiroxCiclopirox Olamine19$402
Ciclopirox13$395
Doxycycline Hyclate32$378
Cefdinir19$361
Terbinafine Hcl56$325
Mupirocin35$319
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen47$241
Triamcinolone Acetonide22$235
Methylprednisolone23$190
Duloxetine Hcl11$178
Nortriptyline Hcl12$128
Levofloxacin25$121

Paid to pharmacies, not to this prescriber.

Other podiatrist in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →